Susquehanna Reaffirms Neutral Rating for Humana Inc. (HUM)
Humana Inc. (NYSE:HUM)‘s stock had its “neutral” rating restated by stock analysts at Susquehanna in a research note issued on Thursday. They currently have a $180.00 price objective on the insurance provider’s stock. Susquehanna’s target price would suggest a potential upside of 6.21% from the company’s current price.
Several other equities research analysts also recently issued reports on HUM. Leerink Swann reissued an “outperform” rating on shares of Humana in a research note on Tuesday, June 21st. Wolfe Research initiated coverage on Humana in a research note on Tuesday, June 28th. They set a “market perform” rating and a $244.00 price target for the company. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. JPMorgan Chase & Co. downgraded Humana from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a research note on Saturday, July 9th. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Humana has a consensus rating of “Buy” and an average target price of $200.50.
Humana (NYSE:HUM) traded up 0.62% during trading on Thursday, reaching $169.48. The company’s stock had a trading volume of 1,635,324 shares. The stock’s 50-day moving average is $176.12 and its 200 day moving average is $175.83. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The firm has a market capitalization of $25.26 billion, a price-to-earnings ratio of 26.04 and a beta of 0.90.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/susquehanna-reaffirms-neutral-rating-for-humana-inc-hum.html
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.07. The firm earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.67 EPS. On average, analysts predict that Humana will post $9.24 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be given a $0.29 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. Humana’s dividend payout ratio is currently 18.18%.
Several hedge funds have recently made changes to their positions in the company. Point72 Asia Hong Kong Ltd bought a new position in Humana during the second quarter valued at approximately $126,000. Daiwa SB Investments Ltd. increased its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the period. Bessemer Group Inc. increased its position in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the period. Fulton Bank N.A. bought a new position in Humana during the third quarter valued at approximately $229,000. Finally, BB&T Securities LLC increased its position in Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares during the period. Institutional investors own 93.24% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.